Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
445 |
|
Actual shortage: | 57 (13%) | |
Anticipated shortage: | 14 (3%) | |
Avoided shortage: | 8 (2%) | |
Resolved: | 366 (82%) | |
Discontinuation Reports |
68 |
|
To be discontinued: | 7 (10%) | |
Discontinued: | 51 (75%) | |
Reversed: | 10 (15%) | |
Late reports |
44 (9%) |
|
Overdue reports |
13 (17%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
GALANTAMINE ER | 16MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-10-23 | 2024-04-04 | 207850 |
GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2024-02-13 | 2024-04-04 | 219378 |
GLICLAZIDE MR | 60MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-03-26 | 2024-03-27 | 223453 |
GLICLAZIDE MR | 30MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-03-26 | 2024-03-26 | 223456 |
IMATINIB | 100MG | TABLET | Anticipated shortage | 2024-04-19 | 2024-04-19 | 225711 |
IMATINIB | 400MG | TABLET | Anticipated shortage | 2024-04-19 | 2024-04-19 | 225714 |
IRBESARTAN | 75MG | TABLET | Resolved | 2018-10-01 | 2018-10-31 | 62786 |
IRBESARTAN | 150MG | TABLET | Resolved | 2018-10-01 | 2018-10-31 | 62789 |
IRBESARTAN | 75MG | TABLET | Resolved | 2019-04-26 | 2019-06-04 | 82512 |
IRBESARTAN | 75MG | TABLET | Resolved | 2019-06-10 | 2019-11-28 | 86038 |
IRBESARTAN | 150MG | TABLET | Resolved | 2020-03-10 | 2021-02-10 | 108341 |
IRBESARTAN | 300MG | TABLET | Resolved | 2020-03-10 | 2021-09-14 | 108344 |
IRBESARTAN | 75MG | TABLET | Resolved | 2020-03-10 | 2021-07-08 | 108347 |
IRBESARTAN | 150MG | TABLET | Resolved | 2023-06-27 | 2023-11-13 | 196716 |
IRBESARTAN | 300MG | TABLET | Resolved | 2023-10-23 | 2024-02-29 | 207903 |
IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Resolved | 2018-03-07 | 2018-04-13 | 42112 |
IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Resolved | 2018-08-14 | 2018-09-05 | 58073 |
IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Resolved | 2019-01-28 | 2019-04-09 | 73693 |
IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Resolved | 2020-01-20 | 2020-03-04 | 103707 |
IRBESARTAN/HCTZ | 12.5MG 300MG | TABLET | Resolved | 2020-01-20 | 2021-09-14 | 103710 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
DILTIAZEM CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2416 |
DILTIAZEM CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2421 |
DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107342 | ||
DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107353 | ||
DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107357 | ||
DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107364 | ||
DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2389 |
DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107369 | ||
DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107372 | ||
DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107375 | ||
DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | To be discontinued | 2024-02-15 | 2024-02-15 | 219591 |
DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |
ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4959 |
FENOFIBRATE MICRO | 200MG | CAPSULE | Discontinued | 2017-08-02 | 2017-08-02 | 17972 |
FENOFIBRATE-S | 100MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4891 |
FENOFIBRATE-S | 160MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4894 |
HYDROXYUREA | 500MG | CAPSULE | Discontinued | 2017-04-03 | 2017-04-03 | 5084 |
INDAPAMIDE | 2.5MG | TABLET | Discontinued | 2017-03-14 | 2017-03-14 | 2450 |